MedImpact is not requiring patients currently taking Humira to switch, and all three products are on a preferred tier. MedImpact Healthcare Systems is providing access to two Humira biosimilars: ...

Beginning in 2025, Express Scripts will favor biosimilars of Humira, including its own private-label version. Beginning in 2025, Express Scripts will remove Humira (adalimumab) from its commercial ...

I appreciate that Malik Willis avoided throwing an interception. And I understand without AJBrown, his receiving corps is more of a corpse. But at some point late in that game, he just needed to ...

It could also mount a challenge to Roche’s fast-growing MS therapy Ocrevus (ocrelizumab). Novartis already markets the CD20-targeting drug for chronic lymphocytic leukaemia (CLL) as Arzerra ...

During the first half of this year, Ocrevus generated 1.04 billion Swiss francs – more than 90% of that was from use in the US. Roche’s MS drug Ocrevus earns blockbuster status a year after ...